Novo Nordisk is a Danish multinational biotech company with production facilities in seven countries and affiliates or offices in 80 countries. Diabetes care, haemophilia care, growth hormone therapy, and hormone replacement therapy are the primary areas of focus for the company. Levemir, NovoLog, Novolin R, NovoSeven, NovoEight, and Victoza are among the drugs manufactured by the company.
Regeneron is a biopharmaceutical company that develops and markets drugs for patients suffering from eye disease, cancer, cardiovascular disease, allergic and inflammatory issues, and infectious diseases. The company intends to run one of the world’s largest gene sequencing operations through its Regeneron Genetics Center.
Alexion is a biopharmaceutical company that develops and sells immunoregulatory drugs to treat cardiovascular and autoimmune diseases. Alexion’s drug therapies aim to provide patients with compounds that selectively target parts of the immune system that may allow diseases to spread.
Vertex is a biopharmaceutical company that develops and markets drug treatments for patients suffering from cancer, cystic fibrosis, autoimmune diseases, and neurological disorders, among other things.
Jazz Pharmaceuticals is an Irish biopharmaceutical company that develops and commercialises drugs to treat narcolepsy, psychiatry, pain management, and oncology. On March 25, the company announced that its drug JZP-258 had been approved by the FDA for the treatment of cataplexy or excessive daytime sleepiness.
Focusing on small molecule drugs for use in oncology primarily, Incyte is a biopharmaceutical company responsible for discovering, developing, and marketing drug therapies. The company is best known for its drug Jakafi, a treatment for myelofibrosis.